Newsroom | 5090 results

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2026 results after the financial markets close on Thursday, May 7, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2026 financial and operating results. A live webcast of the call will be available on Tandem Diabetes...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2026 financial results after market close on Thursday, April 30, 2026. Management will hold a conference call to review the company's first quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financial results for the first quarter of 2026 on Wednesday, May 6, 2026, before the opening of the financial markets. In connection with the release, management will host a conference call that day at 8:00 a.m. (Eastern Time). The link to the live call will be available on the Inves...

CHARLOTTE, N.C. & CARDIFF, Verenigd Koninkrijk--(BUSINESS WIRE)--Tanner Pharma Group, een wereldwijde aanbieder van oplossingen voor de toegang tot gespecialiseerde geneesmiddelen, en Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), een biofarmaceutisch bedrijf in de klinische fase dat innovatieve producten voor maag-darmkanker ontwikkelt, hebben een strategisch partnerschap aangekondigd. Het doel is om patiënten met familiale adenomateuze polyposis (FAP) wereldwijd toegang te bieden tot eRapa via e...

CHARLOTTE, North Carolina e CARDIFF, Regno Unito--(BUSINESS WIRE)--Tanner Pharma Group, fornitore globale di soluzioni di accesso a medicinali specifici e Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), un'azienda biofarmaceutica di fase clinica che sviluppa prodotti innovativi per tumori gastrointestinali, hanno annunciato una partnership strategica per consentire l'accesso globale a eRapa per i pazienti affetti da poliposi adenomatosa familiare (FAP) tramite un programma di accesso anticipato/per...

CHARLOTTE (Carolina del Norte) y CARDIFF (Reino Unido)--(BUSINESS WIRE)--Tanner Pharma Group, proveedor global de soluciones de acceso a medicina especializada, y Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), empresa biofarmacéutica de fase clínica que desarrolla productos innovadores para tipos de cáncer gastrointestinales, anunciaron una alianza estratégica para posibilitar el acceso global a eRapa para pacientes con poliposis adenomatosa familiar (PAF) a través de un programa de acceso anticip...

CHARLOTTE, Caroline du Nord & CARDIFF, Royaume-Uni--(BUSINESS WIRE)--Tanner Pharma Group, un fournisseur mondial de solutions d’accès aux médicaments spécialisés, et Biodexa Pharmaceuticals PLC (Nasdaq : BDRX), une société biopharmaceutique de stade clinique qui développe des produits innovants pour le traitement des cancers gastro-intestinaux, ont annoncé un partenariat stratégique visant à permettre l’accès mondial à eRapa pour les patients atteints de polypose adénomateuse familiale (PAF) da...

CHARLOTTE, North Carolina, und CARDIFF, Vereinigtes Königreich--(BUSINESS WIRE)--Tanner Pharma Group, ein globaler Anbieter von Zugangslösungen für Spezialmedikamente, und Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), ein im klinischen Stadium tätiges Biotechnologieunternehmen, das innovative Produkte für die Behandlung von gastrointestinalen Krebserkrankungen entwickelt, gaben jetzt eine strategische Partnerschaft bekannt, durch die ein globaler Zugang zu eRapa für Patienten mit familiärer adeno...

CHARLOTTE, N.C. & CARDIFF, United Kingdom--(BUSINESS WIRE)--Tanner Pharma and Biodexa have partnered to enable global access to eRapa for FAP patients through an Early Access Program....

ACTON, Mass.--(BUSINESS WIRE)--Insulet Appoints Mike Panos as Chief Commercial Officer...